The teams will develop technological solutions to improve patient care and improve the well-being of patients. Frontline healthcare heroes
BETHLEHEM, Pa., May 10, 2022 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today announced a collaboration agreement with Massachusetts General Hospital (MGH ), one of the nation’s leading research hospitals, to jointly develop innovative solutions to help frontline healthcare workers improve patient care and reduce daily stress caused by unprecedented on-site demands. of work. The collaboration will focus on bringing nursing business ideas and models to life to deliver care more efficiently and productively, while improving work life and the well-being of care teams.
“After more than two years of battling the pandemic and dealing with workforce shortages and supply chain disruptions, our frontline healthcare staff are facing physical and emotional fatigue that needs to be addressed. dealt with from many different angles,” said Hiam Nadel, MBA, CCG RN, Director of the Center for Innovations in Care Delivery at the MGH. “We believe that some of the best ideas will come from the frontline workers themselves who know best the challenges of delivering quality care in extraordinary circumstances. Our goal is to identify the most promising solutions, leverage the latest technologies to develop testable prototypes and obtain the necessary resources to make them a reality.”
The innovation teams that will form as part of the collaboration will be made up of interdisciplinary colleagues from B. Braun and MGH. By combining B. Braun’s dedicated cross-functional incubator team with over 200 years of business, technology and operational expertise, along with MGH’s formidable clinical and medical expertise, teams can quickly push the boundaries of technology in the field of health, in particular with regard to digital documentation. fatigue.
“From research and practical experience in the field, we know that nurses have more direct interaction with patients than any other healthcare professional, giving them the best perspective on what works and doesn’t work. not,” said Mike Golebiowski, Corporate Vice President, Healthcare Strategy and Innovation at B. Braun. “This is especially true coming out of the pandemic, when nurses and other frontline workers have been forced to innovate on the run. B. Braun’s goal in working with MGH is to tap into this mindset innovation and drive adoption of solutions to improve patient health while easing the burden on those providing care.
B. Braun and MGH plan to publish the various results from this collaboration, in the hope of pursuing the commercialization of technologies that have the greatest potential for adoption by other health systems.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures and markets medical products and services for the healthcare industry. Other key product areas include nutrition, pharmaceutical blends and dialysis. The company is committed to eliminating preventable treatment errors and improving safety for patients, clinicians and the environment. B. Braun Medical is headquartered in Bethlehem, Pennsylvania, and is part of the B. Braun group of companies in the United States, which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun group of companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with its customers, partners and clinicians to solve critical issues of improving care and reducing costs. To learn more about B. Braun Medical, explore our website.
SOURCEB. Braun Medical Inc.